|
|
 |
|
Viewing report
|
|
|
|
China Pharmaceutical Market Report 2011
Pacific Bridge Medical, Jan 2011, Pages: 92
China's pharmaceutical market is a large, rising opportunity – reaching an estimated $38 billion in 2009 and still growing at almost 20% annually. By 2012, China should rank as the world’s third largest pharmaceutical market and is expected to grow to $100 billion by 2015. This makes it strategically crucial for Western pharmaceutical companies to succeed in China. However, the Chinese pharmaceutical market has unique characteristics which must be understood to make the China potential a reality.
This research report contains key information on multiple important topics of the Chinese pharmaceutical market, including market data, the role of government health insurance reimbursement, government price controls, institutional purchasing practices, differing characteristics and business strategies of domestic and foreign pharmaceutical companies, and more. It also includes three appendices: one on recent acquisitions, ventures, and partnerships in the Chinese drug industry; a list of all drugs which Chinese government health insurance will reimburse; and contact information for key Chinese drug agencies.
This report has 38 pages + a 54-page appendix.
Updates for 2011 include:
- Latest health and pharmaceutical market projections for China
- Recent Chinese healthcare reforms and their impact on foreign medical investment
- Latest drug pricing policies impacting foreign pharmaceutical companies
- Latest drug reimbursement policies affecting foreign drug demand
|
|
|
|
